Status:
NOT_YET_RECRUITING
Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Lead Sponsor:
Liverpool University Hospitals NHS Foundation Trust
Conditions:
Haemodialysis Complication
Major Adverse Cardiac Events
Eligibility:
All Genders
18+ years
Brief Summary
Chronic kidney disease (CKD) is a long-term condition where the kidneys do not work as well as they should. End-stage kidney failure (ESKD) is the final, irreparable stage of chronic kidney disease (C...
Detailed Description
Currently, there is no specific approach to stratify CV risk in HD patients; therefore, patients are not offered targeted preventative interventions. This novel project will characterise circulating b...
Eligibility Criteria
Inclusion
- Patients aged≥45 years (or ≥18 with a history of diabetes). b. Cases: Incident haemodialysis patients c. A comparative arm of peritoneal dialysis patients and CKD 3-4 (not on dialysis) with hypertension as a key risk factor for CVD.
- d. Capable of understanding the purpose and risks of the study, fully informed, and given informed consent.
Exclusion
- Patients with pre-existing heart disease will be excluded.
- Patients with active cancer.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06037759
Start Date
November 1 2023
End Date
November 1 2026
Last Update
September 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.